COVID-19 thromboembolism incidence, risk factors, and anticoagulation practices from a Chicago metropolitan US population

Am J Hematol. 2022 Jun 1;97(6):E217-E220. doi: 10.1002/ajh.26541. Epub 2022 Mar 28.

Stephanie Berg^{1

2}, Seo-Hyun Kim³, Amy Wozniak⁴, Oluwatobi Odetola², Saad Arain⁵, Ahmed Aleem², James Coggan³, Ami Dave⁶, Elizabeth Elliott¹, Ryan Guerrettaz², Hina Dalal², Raymond Lee², Abhigna Kodali⁵, Patrick Moore¹, Sonam Patel¹, Priya Rajakumar³, Shuai Qin¹, Glenda Delgado Ramos¹, Candice Schwartz⁵, Fatema Esmail¹, Rebecca Feltman Frank⁷, Ellen Murchie⁷, Laura Pax⁷, Nicole Yun^{2

6}, Yanyu Zhang⁶, Kevin Barton^{1

2}, Patrick Hagen^{1

2}, Nasheed Hossain^{1

2}, Melissa L Larson³, Hanh Mai^{1

2}, Sucha Nand^{1

2}, Kathleen Phelan¹, Parameswawran Venugopal³, Patrick Stiff^{1

2}, Santosh Saraf^{5

8}

¹ Department of Internal Medicine, Division of Hematology-Oncology, Loyola University Chicago, Maywood, Illinois, USA.
² Department of Internal Medicine, Loyola University Medical Center, Maywood, Illinois, USA.
³ Department of Internal Medicine, Division of Hematology, Rush University Medical Center, Chicago, Illinois, USA.
⁴ Clinical Research Office, Biostatistics Core, Loyola University Chicago, Maywood, Illinois, USA.
⁵ Department of Internal Medicine-Section of Hematology/Oncology, University of Illinois at Chicago, Chicago, Illinois, USA.
⁶ Rush University, Rush Bioinformatics and Biostatistics Core, Chicago, Illinois, USA.
⁷ Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.
⁸ Comprehensive Sickle Cell Center, Department of Internal Medicine, Section of Hematology/Oncology, University of Illinois at Chicago, Chicago, Illinois, USA.

No abstract available

Publication types